Rates of hospitalization for respiratory syncytial virus infection among children in Medicaid

Journal of Pediatrics

Volumn 137, Issue 6, 2000, Pages 865-870

  Boyce, Thomas G ^a,b,c   Mellen, Beverly G ^a,b,c   Mitchel Jr, Edward F ^a,b,c   Wright, Peter F ^a,b,c   Griffin, Marie R ^a,b,c  

^a MAYO CLINIC COLLEGE OF MEDICINE   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CHILD; HOSPITALIZATION; HUMAN; LUNG DYSPLASIA; MAJOR CLINICAL STUDY; MEDICAID; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; VIRUS INFECTION;

EID: 0033638924     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1067/mpd.2000.110531     Document Type: Article

References (15)

1. Prospects for immunizing against respiratory syncytial virus
2. Bronchiolitis-associated hospitalizations among US children, 1980-1996
3. Reduction of respiratory syncytial virus hospitalization among premature infants and infants with bronchopulmonary dysplasia using respiratory syncytial virus immune globulin prophylaxis
4. Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants
5. Prevention of respiratory syncytial virus infections: Indications for the use of palivizumab and update on the use of RSV-IGIV
6. The effect of influenza on hospitalizations, outpatient visits, and courses of antibiotics in children
7. Effect of Medicaid expansions on preterm birth
8. Respiratory Syncytial Virus Immune Globulin Study Group Respiratory syncytial virus (RSV) infection in preterm infants and the protective effects of RSV immune globulin (RSVIG)
9. Prophylactic administration of respiratory syncytial virus immune globulin to high-risk infants and young children
10. Respiratory syncytial virus immune globulin for prophylaxis against respiratory syncytial virus disease in infants and children with congenital heart disease
11. Rehospitalization for respiratory syncytial virus among premature infants
12. Report to the Medical Research Council Subcommittee on Respiratory Syncytial Virus Vaccines. Respiratory syncytial virus infection: Admissions to hospital in industrial, urban, and rural areas
13. Risk of respiratory syncytial virus infection for infants from low-income families in relationship to age, sex, ethnic group, and maternal antibody level
14. Perinatal outcomes following implementation of TennCare
15. Epidemiology and clinical impact of parainfluenza virus infections in otherwise healthy infants and young children <5 years old